CAS NO: 136434-34-9, Duloxetine Hydrochloride. Shodhana with a wide portfolio of Apis and Intermediates manufacturing in its ledger. It is prescribed by doctors as the first line of treatment for patients during the initial stages of the illness. While studies have confirmed its effectiveness in the initial stages of the ailment, further studies are still required to find the spectrum of its effect in the later stages. Depending on the severity of the case, doctors recommend different doses of this drug to their patients. Administering CAS NO: 136434-34-9 – Duloxetine Hydrochloride can have certain side effects such as nausea, somnolence, insomnia, and dizziness.